JNJ is expected to announce Q2 results on July 19, 2016.
Its medical devices business may hamper revenue growth, but the growth in the pharma business ...
19 julio 2016
Jonhson and Johnson Publicara Hoy los Resultados del primer semestre 2016 ... Su Sector Oncologico Podría Aumentar un 30 % este año 2016 . Yondelis , Darzalex y Imbruvica Impulsarían este Crecimiento Cuyas Ventas Podrían dar un Salto de un 190 % este año .
JNJ is expected to announce Q2 results on July 19, 2016.
Its medical devices business may hamper revenue growth, but the growth in the pharma business ...